Drd5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The DRD5 gene encodes the dopamine D5 receptor, a D1-like dopamine receptor with high constitutive activity. It is one of five dopamine receptor subtypes and plays important roles in motor control, cognition, and reward.
| Property |
Value |
| Gene Symbol |
DRD5 |
| Full Name |
Dopamine Receptor D5 |
| Chromosomal Location |
4p15.1 |
| NCBI Gene ID |
1816 |
| UniProt ID |
P21918 |
| Receptor Class |
D1-like (Gs-coupled) |
The D5 receptor is a G protein-coupled receptor (GPCR) with:
- 7 transmembrane domains (typical GPCR structure)
- Long third intracellular loop - important for G protein coupling
- C-terminal tail - involved in desensitization and internalization
- D1-like homology - highly conserved across D1/D5 subtypes
- Constitutive activity - can signal without agonist binding
- N-terminal extracellular domain: Ligand binding site
- Transmembrane helices: 7 hydrophobic segments
- Intracellular loops: G protein coupling domains
- Phosphorylation sites: Serine/threonine for GRK phosphorylation
The D5 receptor has several unique properties:
- Gs coupling: Activates adenylyl cyclase → cAMP increase
- Constitutive activity: Basal signaling without dopamine
- High dopamine affinity: Lower EC50 than D1 receptor
- Motor Control: Facilitates movement initiation
- Cognition: Working memory and attention
- Reward: Positive reinforcement pathways
- Hormone Regulation: Modulates prolactin secretion
- Spatial Learning: Hippocampal-dependent memory
- Striatum: High expression in direct pathway neurons
- Prefrontal Cortex: Moderate expression
- Hippocampus: Important for memory circuits
- Thalamus: Sensory processing modulation
- Olfactory bulb: Peripheral olfactory processing
- D5 Receptor Changes: Altered expression in PD brain
- Therapeutic Target: D1/D5 agonists used in treatment
- L-DOPA Response: D5 may influence dyskinesia development
- Cognitive Dysfunction: D5 in working memory deficits
- Genetic Association: DRD5 variants linked to ADHD risk
- Response to Stimulants: Methylphenidate affects D5 signaling
- Executive Function: D5 in attention and impulsivity
- D5 Expression: Altered in prefrontal cortex
- Cognitive Symptoms: D5 dysfunction may contribute
- Treatment Response: Antipsychotics affect D5 signaling
- Genetic Links: DRD5 variants associated
- Mood Stabilizers: May modulate D5 function
- Mania: Dopamine dysregulation involves D5
- D5 Dysfunction: May contribute to tics
- Haloperidol Response: D2/D5 blockade effective
- Dihrex - selective D1/D5 agonist
- SKF-81297 - D1-like agonist
- A-77636 - D1 agonist with long duration
- Parkinson's Disease: Improve motor function
- Cognitive Enhancement: Working memory improvement
- ADHD: Wakefulness promotion
- Motor complications: Dyskinesias with chronic use
- Psychosis: Agonists can trigger psychosis
- Cardiovascular: Blood pressure effects
- Promoter variants: Affect expression levels
- Coding variants: Altered ligand binding
- Linkage disequilibrium: With other dopaminergic genes
- Treatment Response: Variants predict response
- Side Effects: Dyskinesia risk variants
- Personalized Medicine: Genotype-guided therapy
The study of Drd5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.